Nanoparticle Modulation of Immune and Vascular Microenvironment Dynamics Following Spinal Cord Injury

Area of Science:

• Neuroscience
• Biomaterials Science
• Immunology

Background:

• Spinal cord injury (SCI) triggers inflammation, causing secondary damage and functional loss.
• Methylprednisolone has an unfavorable risk-benefit ratio for SCI treatment.
• Therapeutic nanoparticles (NPs) offer a promising alternative for reducing inflammation and secondary damage in SCI.

Purpose of the Study:

• To investigate the mechanisms by which NPs modulate monocyte and neutrophil behavior during the acute phase of SCI.
• To computationally analyze the intercellular communication network within the SCI microenvironment under NP treatment.
• To elucidate how NPs promote a pro-regenerative environment post-SCI.

Main Methods:

• Adoptive transfer of myeloid cells to track trafficking patterns.
• Single-cell RNA sequencing to analyze cell phenotypes and gene expression.
• Computational analysis of cell-cell communication networks.
• Mouse model of cervical hemisection spinal cord injury.

Main Results:

• NP treatment reduced myeloid cell recruitment to the injury site.
• NP treatment decreased the proportion of inflammatory monocytes and promoted pro-regenerative phenotypes.
• Single-cell sequencing revealed NP-mediated alterations in intercellular signaling, influencing endothelial cells, fibroblasts, and glial cells.
• NP treatment enhanced pro-regenerative gene expression and reduced inhibitors of regeneration.

Conclusions:

• NPs directly and indirectly modulate monocytes and neutrophils post-SCI.
• NP treatment reshapes the cellular microenvironment, promoting angiogenesis, neuroprotection, and axon outgrowth.
• These findings highlight NPs as a potential therapeutic strategy for improving functional recovery after spinal cord injury.